Marshall Wace North America’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-32,569
| Closed | -$264K | – | 1815 |
|
|
2021
Q1 | $264K | Sell |
32,569
-1,542,169
| -98% | -$12.5M | ﹤0.01% | 1314 |
|
|
2020
Q4 | $10.2M | Buy |
+1,574,738
| New | +$10.2M | 0.05% | 374 |
|
|
2019
Q2 | – | Sell |
-19,047
| Closed | -$52K | – | 1718 |
|
|
2019
Q1 | $52K | Buy |
+19,047
| New | +$52K | ﹤0.01% | 1261 |
|
|
2018
Q4 | – | Sell |
-427,000
| Closed | -$4.04M | – | 1685 |
|
|
2018
Q3 | $4.04M | Buy |
+427,000
| New | +$4.04M | 0.03% | 359 |
|
|
2018
Q2 | – | Sell |
-110,209
| Closed | -$1.16M | – | 1772 |
|
|
2018
Q1 | $1.16M | Buy |
+110,209
| New | +$1.16M | 0.01% | 955 |
|
|
2017
Q3 | – | Sell |
-77,315
| Closed | -$541K | – | 1559 |
|
|
2017
Q2 | $541K | Buy |
+77,315
| New | +$541K | ﹤0.01% | 1076 |
|